7248.5000 -56.50 (-0.77%)
NSE Jul 24, 2026 15:59 PM
Volume: 328.9K
 

7248.50
-0.77%
Deven Choksey
We expect the company to grow its Revenue/EBITDA/PAT at a CAGR of 15.3% / 20% / 18.2% for the period of FY26-FY28.
Divi's Laboratories Ltd. is trading above all available SMAs
More from Divi's Laboratories Ltd.
Recommended